Correspondence | Published:

Outcubation—where incubation meets outsourcing

Nature Biotechnology volume 33, pages 2021 (2015) | Download Citation


Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Anonymous. Nat. Biotechnol. 32, 109 (2014).

  2. 2.

    et al. Drug Discov. Today 18, 1133–1137 (2013).

  3. 3.

    Open Innovation: The New Imperative for Creating and Profiting from Technology (Harvard Business School Press, 2003).

  4. 4.

    & Expert Rev. Clin. Pharmacol. 5, 481–483 (2012).

  5. 5.

    & Nat. Rev. Drug Discov. 9, 87–88 (2010).

  6. 6.

    et al. J. Health Econ. 32, 106–113 (2013).

  7. 7.

    Pasteur's Quadrant: Basic Science and Technological Innovation (Brookings Institution Press, 1997).

  8. 8.

    & Harvard Business Review, (October 2013) .

  9. 9.

    J. Transl. Med. 9, 54–57 (2011).

Download references


We thank F. Rippmann, M. Wolf and R. Lindemann for their engagement as industry project champions; R. Wade, M. Patil and V. Umansky for their engagement as academic mentors; A. Miranville, G. Hirschel, O. Bauer, S. Heitz and G. Ries for their contributions in contracting this new model; and A. Wiest, B. Kirschbaum, K. Urbahns, S. Arkinstall, C. Huber and J. Schwiezer for their contributions in the Joint Steering Committee.

Author information


  1. Merck KGaA, Merck Serono, Darmstadt, Germany.

    • Ulrich A K Betz
  2. BioMed X GmbH, Heidelberg, Germany.

    • Christian A Tidona


  1. Search for Ulrich A K Betz in:

  2. Search for Christian A Tidona in:

Competing interests

Christian Tidona is the CEO of BioMed X GmbH and Ulrich Betz works for Merck KGaA as Head of Innovation, Merck Serono.

Corresponding author

Correspondence to Ulrich A K Betz.

About this article

Publication history



Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing